CIK 0000872589
- Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 133444607
- Phone
- +1 914-847-7000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $59,162,329
- in 14 filings, $13.9M under 10b5-1 plans
Net −$59,162,329. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-12 | SCHLEIFER LEONARD S President & CEO | Sale | −19,984 | $572.47 | $11.4M | 493,465 |
| 2020-05-12 | SCHLEIFER LEONARD S President & CEO | Sale | −10,014 | $573.27 | $5.7M | 483,451 |
| 2020-05-12 | SCHLEIFER LEONARD S President & CEO | Sale | −4,390 | $574.59 | $2.5M | 479,061 |
| 2020-05-12 | SCHLEIFER LEONARD S President & CEO | Sale | −2,196 | $575.48 | $1.3M | 476,865 |
| 2020-05-12 | SCHLEIFER LEONARD S President & CEO | Sale | −1,728 | $576.51 | $996K | 475,137 |
| 2020-05-12 | SCHLEIFER LEONARD S President & CEO | Sale | −638 | $577.27 | $368K | 474,499 |
| 2020-05-11 | SCHLEIFER LEONARD S President & CEO | Exercise or conversion | +125,000 | $30.63 | $3.8M | 599,499 |
| 2020-05-11 | SCHLEIFER LEONARD S President & CEO | Shares withheld for taxes | −64,631 | $571.43 | $36.9M | 534,868 |
| 2020-05-11 | SCHLEIFER LEONARD S President & CEO | Exercise or conversion | +187,500 | $30.63 | $5.7M | 722,368 |
| 2020-05-11 | SCHLEIFER LEONARD S President & CEO | Shares withheld for taxes | −96,947 | $571.43 | $55.4M | 625,421 |
| 2020-05-11 | SCHLEIFER LEONARD S President & CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −125,000 | 187,500 | ||
| 2020-05-11 | SCHLEIFER LEONARD S President & CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −187,500 | 0 | ||
| 2020-05-11 | SING GEORGE L Director | Sale | −250 | $575.00 | $144K | 2,150 |
| 2020-05-11 | SING GEORGE L Director | Sale | −300 | $575.00 | $173K | 3,400 |
| 2020-05-11 | SING GEORGE L Director | Sale | −300 | $575.00 | $173K | 8,700 |
| 2020-05-11 | STAHL NEIL EVP Research and Development | Sale | −312 | $567.50 | $177K | 16,373 |
| 2020-05-11 | STAHL NEIL EVP Research and Development | Sale | −792 | $568.71 | $450K | 15,581 |
| 2020-05-11 | STAHL NEIL EVP Research and Development | Sale | −2,175 | $569.39 | $1.2M | 13,406 |
| 2020-05-11 | STAHL NEIL EVP Research and Development | Sale | −2,026 | $570.28 | $1.2M | 11,380 |
| 2020-05-08 | STAHL NEIL EVP Research and Development | Exercise or conversion | +12,500 | $52.03 | $650K | 23,880 |
Page 151 of 181 · 3,603 trades